Optimization of polymerase chain reaction for detection of Clostridium botulinum type C and D in bovine samples by Prevot, V. et al.
ORIGINAL ARTICLE
Optimization of Polymerase Chain Reaction for Detection of
Clostridium botulinum Type C and D in Bovine Samples
V. Prévot1, F. Tweepenninckx1, E. Van Nerom1, A. Linden2, J. Content1 and A. Kimpe1
1 Pasteur Institute of Brussels, Rue Engeland 642, B1180 Bruxelles, Belgium
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Importance of the paper’s findings for a
non-specialist:
1. Developing a fast diagnosis method for botulism.
2. To be able to prevent the disease.
3. Reduce massive economic losses and public health
risk whenever contaminated meat or dairy products enter
the food chain.
Introduction
Botulism is a deadly disease of humans and animals
caused by the neurotoxins produced by the anaerobic bac-
teria Clostridium botulinum. These neurotoxins (BoNT)
are considered to be the most potent of all bacterial toxins
(Lamanna, 1959). In their active form, they consist of two
subunits: a heavy chain (100 kDa) and a light chain
(50 kDa) which are held together by a disulphide bridge
(Niemann, 1991). Their mode of action relies on blocking
the release of the acetylcholine neurotransmitter at the
cholinergic synapses resulting in neuroparalytic disease
that can lead to death (DasGupta, 1990). BoNTs are cate-
gorized into seven different types (A to G) according to
their antigenic properties (Niemann, 1991).
Bovines are principally susceptible to type D toxin;
however, they may also be affected by types C, B and
rarely A. They are usually toxin-infected when grazing
poultry litter-contaminated pastures. However, in devel-
oping countries, these animals may suffer from hypo-
phosphorous conditions and get infected by grazing
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Summary
Botulism is a rare but serious paralytic illness caused by a nerve toxin that is
produced by the bacterium Clostridium botulinum. The economic, medical and
alimentary consequences can be catastrophic in case of an epizooty. A polymer-
ase chain reaction (PCR)-based assay was developed for the detection of
C. botulinum toxigenic strains type C and D in bovine samples. This assay has
proved to be less expensive, faster and simpler to use than the mouse bioassay,
the current reference method for diagnosis of C. botulinum toxigenic strains.
Three pairs of primers were designed, one for global detection of C. botulinum
types C and D (primer pair Y), and two strain-specific pairs specifically
designed for types C (primer pair VC) and D (primer pair VD). The PCR
amplification conditions were optimized and evaluated on 13 bovine and two
duck samples that had been previously tested by the mouse bioassay. In order
to assess the impact of sample treatment, both DNA extracted from crude sam-
ples and three different enrichment broths (TYG, CMM, CMM followed by
TYG) were tested. A 100% sensitivity was observed when samples were
enriched for 5 days in CMM followed by 1 day in TYG broth. False-negative
results were encountered when C. botulinum was screened for in crude samples.
These findings indicate that the current PCR is a reliable method for the detec-
tion of C. botulinum toxigenic strains type C and D in bovine samples but only
after proper enrichment in CMM and TYG broth.
Zoonoses and Public Health
ª 2007 Pasteur Institute of Brussels
320 Journal compilation ª 2007 Blackwell Verlag • Zoonoses Public Health. 54 (2007) 320–327
spore-contaminated ground or carcasses (Carlier et al.,
2001; Afssa, 2002).
The most important clinical signs of botulism in cattle
include loss of tongue tone, decreased upper eyelid and
tail tone, dilated pupils, dysphagia, and decreased ruminal
motility (Whitlock, 1999). Whenever intoxication occurs
in intensively farmed animals, high mortality rates can be
observed (Abbitt et al., 1984; Trueman et al., 1992;
Martin, 2003). Abbitt et al. (1984) found C. botulinum
type D intoxication to be responsible for the death of 42
of 67 lactating cows in a south-east Texas dairy herd over
an 11-day period. The economical, medical and alimen-
tary consequences can be catastrophic in case of an epi-
zooty. One gram of pure toxin dispersed in the food
could kill 400 000 adult cows (Galey et al., 2000).
Symptoms alone are often insufficient to make a diag-
nosis of botulism and a laboratory confirmation is
required. Because of its high sensitivity, the mouse bioas-
say including the identification of the responsible BoNT
by (sero) neutralization, still remains the standard
method in botulism diagnostics (Shone et al., 1985;
Doellgast et al., 1993). However, animal testing remains
highly disapproved and non-specific mouse mortality can
blur the diagnosis (Szabo et al., 1994a).
Treatment of bovine botulism is symptomatic and sup-
portive but not curative. Treating the animal with anti-
toxins only prevents progression of the disease and is
considered only for animals of great commercial value
(Kirk and Adaska, 1998; OVF- Office vétérinaire fédéral,
2002).
In order to prevent botulism epizootic spread both pre-
ventative measures and rapid detection of the causative
agent are of immense importance. In this respect, poly-
merase chain reaction (PCR) seems to be a diagnostic
method with major advantages including rapid, easy and
cheap methodology.
The application of PCR for the detection of neurotoxin
genes has been successful for several different BoNT types
(A, B, C, D, E and F) (Fach et al., 1993, 1995, 2002; Fran-
ciosa et al., 1994, 1996; Szabo et al., 1994a,b; Takeshi
et al., 1996; Aranda et al., 1997; Braconnier et al., 2001;
Dahlenborg et al., 2001; Lindström et al., 2001; Chaffer
et al., 2006). Sensitivity is high; it can detect as little as 35
clostridial bacteria in a sample. However, detection limits
appear to be dependent on the sample type (Wictome
and Shone, 1998). This can be attributed to the presence
of PCR inhibitors and other bacterial species in the sam-
ples (Fach et al., 1993). Therefore, PCR is considered
highly sensitive when used for detection of BoNT genes
in pure cultures in contrast to the detection directly in
crude samples where sensitivity cannot be guaranteed
without prior culture enrichment (Wictome and Shone,
1998).
With the recent achievements in the field of PCR
detection of BoNT genes, we aimed at creating a highly
specific, sensitive, quick and cheap method for the diag-
nosis of C. botulinum types C and D in bovine samples.
In this light, we designed three sets of primers, optimized
the PCR conditions, tested the optimized conditions in
bovine samples and compared these results with the stan-
dard method. Testing of crude samples as well as different
enrichment broths was also incorporated.
Materials and Methods
Bacterial strains
A total of 26 reference strains (15 C. botulinum and 11
other Clostridium species) were included in this study
(Table 1). All reference strains were tested for BoNT pro-
duction in the mouse bioassay as described below.
Sixteen clinical and field samples were collected from
suspected cases (liver, stomach contents, kidney, brain
and feed) (Table 1). Thirteen of these 16 samples tested
positive for toxin production in the mouse bioassay. The
remaining three samples tested negative in the same assay
and were used as negative controls.
Mouse bioassay
All procedures with animals were carried out in accor-
dance to appropriate humane methods. Swiss OF1 con-
ventional mice were used. Breeding was performed in the
breeding facilities of the Pasteur Institute, agreement
number LA2230389. Mice were feed ad libitum with com-
mercial pellets. Temperature was kept at 21C, ventilation
at 15 refreshments per hour and light regimen was of
12 h light/12 h dark. Cages were of type II long mouse
cages: height = 16 cm, surface = 21 · 37 cm, with 10
mice per cage. Mice were used when they reached a
weight of about 20 g.
The mouse lethality test was performed as described pre-
viously (Kautter and Solomon, 1977). Briefly, after 5 days
of anaerobic incubation in cooked meat medium (CMM)
(Difco BD, Erembodegem-Aalst, Belgium) (Quagliaro,
1977) at 37C, 2 ml of enrichment culture were filtered
over a 0.22 lm Millipore filter (MillexGP, Millipore,
Bruxelles, Belgium). A volume of 0.4 ml of filtered solu-
tion was subsequently injected intraperitoneally into mice
(two mice per sample). For 4 days, the mice were
inspected for clinical symptoms of botulism (pinching of
the waist, laboured breathing, paralysis and death). The
presence and type of botulinum toxin was confirmed by
an in vivo seroneutralization test in mice. Therefore,
225 ll of specific botulinum antitoxins (Centre of Disease
Control, Atlanta, GA, USA) were added to 900 ll of fil-
tered culture medium and incubated for 30 min at 37C.
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Table 1. PCR and mouse bioassay








03B019 Bovine liver Da b ·c 
03B020d Bovine feed D  · 
03B021 Bovine stomach contents D  · 
03B027 Bovine stomach contents D  · 
03B030 Bovine stomach contents D  · 
03B033 Bovine stomach contents D  · 
03B038 Bovine liver + kidney + brain D  · 
03B039 Bovine stomach contents D  · 
03B041 Bovine liver + stomach contents D  · 
03B042 Bovine liver D  · 
03B111 Bovine liver D  · 
03B113 Bovine liver D  · 
05B134 Bovine liver D  · 
05B159 Bovine liver –e · · ·
05B166 Duck Liver – · · ·
05B167 Duck Liver – · · ·
Reference
strains
04I C. botulinum A (CIPf 104.310) A · · ·
04V C. botulinum A (ATCC 3502)g A · · ·
04VI C. botulinum A (ATCC 19397) A · · ·
97I C. botulinum B (IPB)h B · · ·
04IV C. botulinum B (NCTC 7273)i B · · ·
05e C. botulinum B (IPB) B · · ·
04II C. botulinum C (CIP 104.983) C   ·
98I C. botulinum C (IPB) C   ·
02II C. botulinum C (IPB) C   ·
02V C. botulinum D (IPB) D  · 
02VI C. botulinum D (IPB) D  · 
04III C. botulinum D (CIP 105.256) D  · 
05p C. botulinum E (NCTC 08266) E · · ·
05o C. botulinum F (NCTC 10281) F · · ·
05l C. novii A (NCTC 13029) A · · ·
05a C. sordelii (IPB) – · · ·
05b C. difficile (IPB) – · · ·
05c C. bifermentans (IPB) – · · ·
05c C. difficile (IPB) – · · ·
05f C. fallax (IPB) – · · ·
05g C. perfringens (IPB) – · · ·
05k C. sporogenes (NCTC 13020) – · · ·
05m C. butyricum (NCTC 07423) – · · ·
05n C. hastiforme (NCTC 11832) – · · ·
80I C. tetani (ATCC 10779) – · · ·
02X C. sporogenes (IPB) – · · ·
aC. botulinum type detected.
bFragment amplified with the expected size.
cNo amplification.
dIn italic: samples that are not bovine.
eNegative result.
fCIP, Collection de l’Institut Pasteur, Paris, France.
gATCC, American Type Culture Collections, Rockville, MD, USA.
hIPB, Strain isolated at the Institut Pasteur de Bruxelles, Brussels, Belgium.
iNCTC, National Collection of Type Cultures, London, UK.
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A volume of 0.5 ml was then injected intraperitoneally
into mice. The animals were checked for symptoms as
described above.
Culture methods
For PCR optimization stored reference strains were grown
under anaerobic conditions in CMM broth for 5 days at
37C followed by an overnight enrichment under similar
conditions in trypticase yeast extract glucose (TYG) med-
ium (Sebald and Petit, 1994).
Clinical and field samples were grown in various media
(Table 2). Prior to inoculation, some cultures were either
treated with ethanol, heat shocked for 10 min at 80C or
both to enhance C. botulinum recovery.
DNA extraction
DNA extractions were performed with the DNA extrac-
tion Kit GenEluteTM Bacterial Genomic DNA Kit (Sigma,
Bornem, Belgium). Briefly, a volume of 1.8 ml of TYG
culture was centrifuged at 16 060 g. Cell pellets were lysed
with 200 ll of a lysozyme solution (45 mg/ml) and subse-
quently treated with 20 ll of RNase A for 3 min at room
temperature. When extractions were made directly from
the sample, 0.25 g was grinded with lysozyme solution
and treated as described above.
The solution was incubated at 37C for 30 min. After
addition of 20 ll of proteinase K and 200 ll of lysis
solution the mix was incubated for 10 min at 55C.
The Sigma binding columns were prepared by adding
500 ll of column preparation solution and centrifuged
at 13 000 rpm. The elute was discarded. Thereafter, a
volume of 200 ll of ethanol (100%) was added to
the lysate and mixed. The entire content was then
transferred into the binding column and centrifuged at
6090 g for 1 min. Subsequently, the DNA recovered on
the column was washed twice with 500 ll of wash
solution 1 and 500 ll of wash solution respectively at
8000 rpm for 1 min and at 13 000 rpm for 3 min.
DNA was eluted with 200 ll of elution solution and
centrifuged at 8000 rpm for 1 min.
PCR assay
Primer design
The sequences of the different C. botulinum neurotoxin
genes (BoNT/A, BoNT/B, BoNT/C, BoNT/D, BoNT/E,
BoNT/F BoNT/G and the tetanus neurotoxin) were
retrieved from the National Centre for Biotechnology
Information (http://www.ncbi.nlm.nih.gov). The primers
were designed after alignment using the program Wem-
boss from the European Molecular Biology Network
(http://www.embnet.org). The sequences and the locations
of these primers as well as the expected amplicon sizes
are listed in Table 3. One set was chosen in the most
homologous regions of the sequences for BoNT/C and
BoNT/D (primer set Y). Two sets of primers (VC and
VD) were chosen for the specific BoNT/C and BoNT/D
detection, respectively. The primers were tested with the
program Amplify (version 1.2) for primer–dimer forma-
tion and specificity.
PCR optimization
Amplification was carried out in the GENEAmp PCR
system 2700 (Applied Biosystems, Lennik, Belgium). The
cycling conditions were optimized in order to use all prim-
ers sets in a single run. For this, a variation of the annealing
temperature from 40 to 65C was tested as well as various
concentrations of MgCl2 (1.5, 2.5, 3.5 and 4.5 mm).
Table 2. Tested culture methods
Name Description
% of positive detections
Y VC VD
TYG Culture in TYGa 36 0 82
CMM Culture in CMMb 0 0 0
CMM.10 min Culture in CMM heated 10¢ at 80C 0 0 0
CMM.E Culture in CMM treated with ethanolc 0 0 0
CMM.E.10 min Culture in CMM heated 10¢ at 80C and treated with ethanol 0 0 0
TYG ‹ CMM Culture in TYG inoculated with a culture of CMM 100 100 100
TYG ‹ CMM.10 min Culture in TYG inoculated with a culture of CMM heated 10¢ at 80C 100 100 100
TYG ‹ CMM.E Culture in TYG inoculated with a culture of CMM treated with ethanol 100 100 100
The last column gives the percentage of positive samples (tested in the mouse bioassay) that were detected positive by PCR for each type of
culture and each primer.
aAll cultures in TYG were performed overnight at 37C.
bAll cultures in CMM were performed for 5 days at 37C.
cTreatment with ethanol at 50% (v/v) for 30 min at 37C.
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The sensitivity of the method was estimated with a large
range of dilutions from 100 ng to 10 ag of the DNA from
the reference strains (Table 1) in order to determine the
lowest concentration allowing detection. The specificity of
the primers was tested in the presence of DNA from other
types of BoNT and with other Clostridia listed in Table 1.
The PCR cycling is a modification of the protocol
described previously by Fach in 1993 (Fach et al., 1993).
The cycling began with an initial step at 95C for 15 min
to activate the HotStart Taq polymerase (Eurogentec,
Seraing, Belgium). Each following cycle consisted of a
denaturation step at 94C for 30 s, an annealing step at
55C for 30 s, and an extension step at 72C for 30 s.
This was repeated 40 times. A final step at 72C for
10 min followed to complete extension.
Positive controls with DNA from reference strains and
a negative control containing all reagents except DNA
template were included during amplification. The ampli-
fied PCR products were visualized in 1.8% agarose gels
(Agarose ultra Pure; GibcoBRL, Merelbeke, Belgium) and
stained with ethidium bromide (molecular weight marker:
Smart Ladder SFTM; Eurogentec). After optimization,
clinical samples were tested by PCR.
Results
PCR optimization
The optimal PCR conditions were set as follows: a final
reaction volume of 50 ll containing 25 ll of Mix PCR
(Red’y’Star Mix from Eurogentec, PK-0073-02R), 3.5 mm
of MgCl2, 0.5 lm concentrations of each primer
(Operon, Cologne, Germany) and 10 ll of template
(100 ng of sample DNA). The optimal annealing temper-
ature was set at 55C. The lowest concentration of DNA
detectable for primers Y, VC and VD was set at 100 fg,
1 pg and 10 fg respectively.
The specificity of the primers was confirmed. None of
the other C. botulinum types and Clostridia tested were
amplified with either of the three sets of primers (Fig. 1
shows some of the results). All C. botulinum type C
strains tested positive for the amplification of a 327 bp
and 169 bp DNA fragments when primers Y and VC were
used, respectively. All C. botulinum type D strains were
found positive for the amplification of a 327-bp fragment
(primers Y) and a 264-bp fragment (primers VD)
(Fig. 1). In order to confirm the results, most of the seg-
ments amplified in the PCR optimization were sequenced.
Application of the optimized PCR in routine samples
Sixteen routine samples enriched in CMM medium
(5 days) followed by an overnight culture (16 h) in TYG
broth were analysed by the mouse bioassay and subjected
to molecular diagnosis by PCR amplification (Table 1
and Fig. 2).
Figure 2 shows the results of amplification of routine
samples 03B019, 03B039 and 03B134 with primer set Y,
VC and VD. These three samples were tested positive for















cds2 Y tttatacgagaatgttcyg C and D 2343–2362 AB037166 AB012112 Hca 327 bp
cdas3 cattatatcctgatgtatcc C and D 2650–2670
cs1.2 VC tcctcgagttacaagcc C 182–199 AB037166 Lcb 169 bp
cas2 caggaaagggtatatctg C 333–351
ds2 VD ttagactatacagcatccc D 495–514 AB012112 Lcb 264 bp
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Fig. 1. Results of the PCR opt-
imization: amplification of ref-
erence samples with primer set
Y, VC and VD. L, ladder; 04II,
type C; 04III, type D; 98I, type
C; 02V, type D.
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toxin production type D in the mouse bioassay, and
pictures show that primers Y and VD amplify them. No
pictures could be shown for sample amplification with
primer set VC since we didn’t dispose any natural posi-
tive bovine samples for C. botulinum type C.
Polymerase chain reaction testing confirmed the positive
bioassay results of all 13 samples. Cross-reactivity between
type C and D was not encountered. The three remaining
samples that tested negative in the mouse bioassay were
also found to be negative in PCR assay. Of the different
culture methods used (Table 2), 5 days of enrichment in
CMM at 37C followed by overnight incubation in TYG at
the same temperature proved to be the most appropriate.
PCR performed on crude samples and other enrichment
cultures were not reproducible. Only three and four posi-
tive results were confirmed in the PCR assay when crude
samples or 16 h TGY enrichment were used, respectively.
PCR results were also confirmed by sequencing.
Discussion
The prevention and rapid detection of bovine botulism is
a worldwide problem. An epizooty can result in massive
economic losses and public health could be at risk when-
ever contaminated meat or dairy products enter the food
chain. In the search for rapid botulism detection meth-
ods, PCR has already proven its usefulness (Fach et al.,
1993, 1995; Franciosa et al., 1994, 1996; Szabo et al.,
1994a,b; Takeshi et al., 1996). However, as far as bovine
samples are concerned, very little has been studied. In the
studies performed by Fach et al. (1996) and Chaffer et al.
(2006), PCR was used to optimize a diagnostic technique
for bovine samples. Fach et al. (1996) employed a double
PCR. They first amplified a fragment common to BoNT
C1 and D, followed by a separate amplification based on
two primers specifically for the latter toxin types. The
primers were located in the N-terminal domain of the
heavy chain, which is responsible for the translocation of
the light chain into the cytosol. Enrichment of naturally
contaminated animal and food samples was made in TYG
for 48h. Fach et al. found a 89.4% correlation rate with
the standard mouse bioassay and 4.3% false-negative
results. In the study of Chaffer et al. (2006) the samples
were enriched in fortified egg meat medium (FEM) for
5 days and their DNA was amplified with primers based
on those of Takeshi et al. (1996). They were situated
within the light chain of the neurotoxins (catalytic
domain). For their bovine samples, they found 100% cor-
relation between the bio assay and their PCR. However,
only six bovine samples were incorporated in this study.
In contrast to the PCR methods described above, we
set up a new approach to confirm the presence of the
entire BONT/C or D genes. For this, three new pairs of
primers were designed: a general set situated in the heavy
chain (Y) and two specific sets of primers localized in the
light chain of toxin type C (VC) and D (VD), respec-
tively. The simultaneous detection of primer Y and pri-
mer VC or VD amplicons only endorse the presence of
either two C. botulinum toxin genes, as both toxic activity
(light chain) and binding/translocation (heavy chain)
domain will be detected.
Bovine C. botulinum type C cases are rather rare in Bel-
gium. They are more frequently encountered in countries
that entail mixed bovine and avian husbandry like Aus-
tralia and South Africa. PCR sensitivity and specificity for
type BoNT/C was confirmed in our study using the refer-
ence strains; hence it is fair to assume that, under condi-
tion that recommended enrichments are made, bovine
botulinum type C will be detectable. However the lack of
natural positive bovine samples for C. botulinum type C
did not allow us to confirm that bovine botulinum type
C will be indeed detectable.
The primers designed and tested in this study proved
to be highly specific and sensitive for the detection of
BoNT/C and D genes. Results drew out of our PCR tech-
nique were concordant with those from the mouse bioas-
say and a 100% sensitivity level was reached. However,
for this, samples required enrichment in CMM for 5 days
followed by enrichment in TYG broth overnight. The
application of the technique directly on crude samples
and enrichment culture of just one night in TYG broth
resulted in false-negative results. For these samples, our
PCR hitherto remains inadequate. This could be due to a






















Y VC VD L Y VC VD L Y VC VD
Fig. 2. Results of amplification
of routine samples 03B019,
03B039 and 03B134 with
primer set Y, VC and VD. L,
ladder.
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or even the presence of large numbers of concomitant
bacteria, proteases, chelators or other Taq polymerase
inhibitory factors remaining in the crude sample (Thomas
et al., 1991; Wilson et al., 1991). These factors are vari-
able according to sample origin and conservation condi-
tions. Therefore, sample treatment as well as culture
method, depend on sample nature and conservation
status (Fach et al., 1993).
Internal amplification controls should be routinely
included in diagnostic PCR to control inhibition by the
sample material. So far reports on their use in the molecu-
lar diagnostics of C. botulinum are limited: Fach et al.
(2002) developed a synthetic internal control (IC) that was
able to coamplify the bont/A, bont/B, bont/E, and bont/F
genes in the same reaction. IC is a recombinant pMOS
Blue plasmid DNA with CB1 and P261 primer-binding
regions, flanking a DNA sequence of the chloramphenicol
resistance gene (Cmr) from Tn9 (Fach et al., 2002).
In order to accelerate the rapidity of our PCR tech-
nique, it would be of interest to realize a reduction in or
even an omission of sample enrichment time. In this light
it would be necessary to find a technique that will elimi-
nate all PCR inhibitors and impeding bacteria present in
the sample. Different types of sample treatment (heat
and/or ethanol) have shown to be useful for some sam-
ples but could not be extrapolated for others (F. Twee-
penninckx, E. Van Nerom and V. Prévot, unpublished
observations). We were unable to standardize sample
treatment to be used systematically.
Unfortunately, until now no efficient selective media for
isolation of C. botulinum are available (Fach et al., 2002).
An alternative method to ‘purify’ samples has yet to be dis-
covered. In this light, miscellaneous methods can be pro-
posed: antibiotic treatment to eliminate contaminant
bacteria (a mixture of cycloserine 1%, sulfomethoxazole
1.9% and trimethoprim 0.1% is already used in some
cases; Dezfulian et al., 1981); development of a matrix
capable of eliminating the Taq polymerase inhibitors
directly from the samples or refining methods permitting
the recovery of merely C. botulinum DNA after extraction.
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